Long-term safety, tolerability, and efficacy of fremanezumab in migraine
Long-term safety, tolerability, and efficacy of fremanezumab in migraine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term safety, tolerability, and efficacy of fremanezumab in migraine have?
Long-term safety, tolerability, and efficacy of fremanezumab in migraine has 178 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term safety, tolerability, and efficacy of fremanezumab in migraine published?
Long-term safety, tolerability, and efficacy of fremanezumab in migraine has 2020 year in the ScholarIQ index.
What is the open-access status of Long-term safety, tolerability, and efficacy of fremanezumab in migraine?
Long-term safety, tolerability, and efficacy of fremanezumab in migraine has hybrid oa status in the ScholarIQ index.
What is the DOI of Long-term safety, tolerability, and efficacy of fremanezumab in migraine?
The DOI for Long-term safety, tolerability, and efficacy of fremanezumab in migraine is on the source record.
What is the PMID of Long-term safety, tolerability, and efficacy of fremanezumab in migraine?
The PMID for Long-term safety, tolerability, and efficacy of fremanezumab in migraine is on the source record.
What is the OpenAlex record for Long-term safety, tolerability, and efficacy of fremanezumab in migraine?
The OpenAlex for Long-term safety, tolerability, and efficacy of fremanezumab in migraine is on the source record.